Hualan Biological Engineering Inc. (SHE:002007)
China
· Delayed Price · Currency is CNY 15.32
+0.02 (0.13%)
Mar 10, 2026, 1:15 PM CST
SHE:002007 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 27,960 | 30,815 | 40,471 | 41,285 | 53,162 | 77,061 | Upgrade
|
| Market Cap Growth | -7.90% | -23.86% | -1.97% | -22.34% | -31.01% | 56.26% | Upgrade
|
| Enterprise Value | 26,217 | 30,967 | 40,161 | 40,273 | 50,356 | 74,541 | Upgrade
|
| Last Close Price | 15.30 | 16.14 | 20.83 | 21.01 | 26.79 | 38.52 | Upgrade
|
| PE Ratio | 29.46 | 28.33 | 27.32 | 38.36 | 40.93 | 47.77 | Upgrade
|
| Forward PE | 16.11 | 19.37 | 23.05 | 28.47 | 27.36 | 47.46 | Upgrade
|
| PS Ratio | 6.55 | 7.04 | 7.58 | 9.14 | 11.98 | 15.34 | Upgrade
|
| PB Ratio | 2.11 | 2.23 | 3.02 | 3.38 | 5.87 | 9.51 | Upgrade
|
| P/TBV Ratio | 2.53 | 2.67 | 3.67 | 4.09 | 6.54 | 10.51 | Upgrade
|
| P/FCF Ratio | 25.33 | 38.33 | 68.31 | 73.28 | 85.59 | 109.49 | Upgrade
|
| P/OCF Ratio | 26.62 | 29.09 | 30.07 | 43.13 | 37.11 | 58.15 | Upgrade
|
| PEG Ratio | 2.04 | 5.16 | 5.16 | 5.16 | 5.16 | 5.16 | Upgrade
|
| EV/Sales Ratio | 6.14 | 7.07 | 7.52 | 8.92 | 11.35 | 14.84 | Upgrade
|
| EV/EBITDA Ratio | 21.25 | 21.52 | 19.41 | 26.92 | 28.25 | 34.21 | Upgrade
|
| EV/EBIT Ratio | 26.96 | 26.27 | 22.18 | 32.92 | 31.75 | 37.32 | Upgrade
|
| EV/FCF Ratio | 23.75 | 38.52 | 67.79 | 71.49 | 81.07 | 105.91 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.07 | 0.08 | 0.09 | 0.11 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.37 | 0.63 | 0.49 | 0.74 | 0.56 | 0.18 | Upgrade
|
| Debt / FCF Ratio | 0.41 | 1.13 | 1.71 | 1.97 | 1.61 | 0.57 | Upgrade
|
| Net Debt / Equity Ratio | -0.27 | -0.17 | -0.16 | -0.19 | -0.26 | -0.45 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.94 | -1.63 | -1.01 | -1.58 | -1.32 | -1.66 | Upgrade
|
| Net Debt / FCF Ratio | -3.28 | -2.92 | -3.54 | -4.18 | -3.78 | -5.15 | Upgrade
|
| Asset Turnover | 0.26 | 0.27 | 0.35 | 0.34 | 0.41 | 0.57 | Upgrade
|
| Inventory Turnover | 0.89 | 0.96 | 1.11 | 1.21 | 1.21 | 1.20 | Upgrade
|
| Quick Ratio | 2.16 | 2.26 | 2.21 | 2.74 | 2.46 | 3.29 | Upgrade
|
| Current Ratio | 3.43 | 4.07 | 3.61 | 3.76 | 3.09 | 3.92 | Upgrade
|
| Return on Equity (ROE) | 7.21% | 8.48% | 13.75% | 11.73% | 16.94% | 24.62% | Upgrade
|
| Return on Assets (ROA) | 3.76% | 4.54% | 7.34% | 5.82% | 9.19% | 14.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.11% | 8.92% | 14.50% | 12.90% | 24.42% | 40.89% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.30% | 8.40% | 13.40% | 9.70% | 17.00% | 24.60% | Upgrade
|
| Earnings Yield | 3.39% | 3.53% | 3.66% | 2.61% | 2.44% | 2.09% | Upgrade
|
| FCF Yield | 3.95% | 2.61% | 1.46% | 1.36% | 1.17% | 0.91% | Upgrade
|
| Dividend Yield | 3.27% | 1.24% | 1.44% | 1.43% | 0.75% | 0.78% | Upgrade
|
| Payout Ratio | 34.97% | 43.00% | 38.04% | 37.12% | 43.43% | 35.43% | Upgrade
|
| Buyback Yield / Dilution | 0.16% | -0.23% | 0.19% | 0.17% | -0.59% | -0.13% | Upgrade
|
| Total Shareholder Return | 3.43% | 1.01% | 1.63% | 1.60% | 0.16% | 0.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.